Evidence map›Paper›PMID 27651826›Full record

ArticleAlgorithms for molecular biology : AMB2016

Using a constraint-based regression method for relative quantification of somatic mutations in pyrosequencing signals: a case for NRAS analysis.

Jerome Ambroise, Jamal Badir, Louise Nienhaus, Annie Robert, Anne-France Dekairelle, Jean-Luc Gala

Abstract read
In one paragraph

Article in Algorithms for molecular biology : AMB, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jerome Ambroise *Institut de Recherche Expérimentale et Clinique (IREC), Center for Applied Molecular Technologies (CTMA), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, 1200 Brussels, Belgium.
Jamal Badir *Institut de Recherche Expérimentale et Clinique (IREC), Center for Applied Molecular Technologies (CTMA), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, 1200 Brussels, Belgium.
Louise NienhausInstitut de Recherche Expérimentale et Clinique (IREC), Center for Applied Molecular Technologies (CTMA), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, 1200 Brussels, Belgium.
Annie RobertEpidemiology and Biostatistics Department (EPID), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, 1200 Brussels, Belgium.
Anne-France DekairelleInstitut de Recherche Expérimentale et Clinique (IREC), Center for Applied Molecular Technologies (CTMA), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, 1200 Brussels, Belgium.
Jean-Luc GalaInstitut de Recherche Expérimentale et Clinique (IREC), Center for Applied Molecular Technologies (CTMA), Université catholique de Louvain, Clos chapelle-aux-champs B1.30.24, 1200 Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPyrosequencing Allele Quantification (AQ) is a cost-effective DNA sequencing method that can be used for detecting somatic mutations in formalin-fixed paraffin-embedded (FFPE) samples. The method displays a low turnaround time and a high sensitivity. Pyrosequencing suffers however from two main drawbacks including (i) low specificity and (ii) difficult signal interpretation when multiple mutations are reported in a hotspot genomic region.

resultsUsing a constraint-based regression method, the new AdvISER-PYRO-SMQ algorithm was developed in the current study and implemented into an R package. As a proof-of-concept, AdvISER-PYRO-SMQ was used to identify a set of 9 distinct point mutations affecting codon 61 of the NRAS oncogene. In parallel, a pyrosequencing assay using the Qiagen software and its AQ module was used to assess selectively the presence of a single point mutation (NRAS[Formula: see text] - Q61R-1) among the set of codon 61 mutations, and to analyze related pyrosequencing signals. AdvISER-PYRO-SMQ produced a lower limit of blank (0 %) than the AQ module of Qiagen software (5.1 %) and similar limit of detection were obtained for both software (5.6 vs 4.8 %). AdvISER-PYRO-SMQ was able to screen for the presence of 9 distinct mutations with a single pyrosequencing reaction whereas the AQ module was limited to screen a single mutation per reaction.

conclusionUsing a constraint-based regression method enables to analyze pyrosequencing signal and to detect multiple mutations within a hotspot genomic region with an optimal compromise between sensitivity and specificity. The AdvISER-PYRO-SMQ R package provides a generic tool which can be applied on a wide range of somatic mutations. Its implementation in a Shiny web interactive application (available at https://ucl-irec-ctma.shinyapps.io/Pyrosequencing-NRAS-61/) enables its use in research or clinical routine applications.

Indexed as

AdvISER-PYRO-SMQPyrosequencingsomaticSparse representation

Identifiers

PMID27651826
PMCPMC5024468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.